Effects of dapagliflozin on serum and urinary uric acid levels in patients with type 2 diabetes: a prospective pilot trial

Effects of dapagliflozin on serum and urinary uric acid levels in patients with type 2 diabetes: a prospective pilot trial

Abstract Background We aimed to evaluate the effects of short-term therapy with dapagliflozin on serum uric acid (SUA) and urinary uric acid (UUA) levels in patients with type 2 diabetes. Methods In this prospective pilot trial, 8 patients with type 2 diabetes mellitus were assigned to the treatment...

Full description

Bibliographic Details
Main Authors: Tao Yuan, Shixuan Liu, Yingyue Dong, Yong Fu, Yan Tang, Weigang Zhao
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Serum uric acid
Fractional excretion of uric acid
Dapagliflozin
Type 2 diabetes mellitus
Islet β-cell function
SGLT2 inhibitors
Online Access:http://link.springer.com/article/10.1186/s13098-020-00600-9

Internet

http://link.springer.com/article/10.1186/s13098-020-00600-9

Similar Items